Comparison of plasms solution versus plasms solution with albumin in patients undergoing pancreatico-duodenectomy

Comparison of Plasms solution versus Plasms solution with albumin in patients undergoing pancreatico-duodenectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0002759

Enrollment

200

Registered

2018-03-28

Start date

2018-04-09

Completion date

Unknown

Last updated

2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : After induction of anesthesia, plasma A group(control group): intraoperative infusion of Plasma solution A 200 ml at a rate of 4 ml/kg/h plasma A + ALBUMIN group(study group): intraoperative in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient undergoing pancreatectomy with American Society of Anesthesiologist classification of 1, 2, 3 and aged between 20 - 80 years

Exclusion criteria

Exclusion criteria: cardiac ejection fraction 1.8 mg/dl, platelet counts 1.5, Body Mass index >35, corticosteroid equivalent > 10 mg prednisolone /day, active sepsis or bacteremia, uncontrolled Diabetes mellitus (HbA1C> 7.0% or fasting glucose > 200 mg/dl)

Design outcomes

Primary

Measure	Time frame
Clavien-Dindo surgical complication	—

Secondary

Measure	Time frame
surgery specific complications;cardiac output;urine output;hospital stay;mortality	—

Countries

Korea, Republic of

Contacts

Public Contactjieae kim

Samsung Medical Center

jieae.kim@samsung.com+82-2-3410-0363

Outcome results